Pharmacists in Fort Walton Beach, Florida


59 Pharmacists found in Fort Walton Beach
female pharmacist

Ms. Somer Alexandria Marshall


Pharmacist
610 Eglin Pkwy Ne, Fort Walton Beach, FL 32547
334-318-9872    

female pharmacist

Stacy Marie Vaughn Stephens


Pharmacist
421 Mary Esther Blvd, Fort Walton Beach, FL 32548
850-301-1334     850-301-1339

female pharmacist

Dr. Stephanie Lynn Shidemantle, PHARM.D.


Pharmacist
414c Mary Esther Cto Nw, Fort Walton Beach, FL 32548
850-244-0869     850-244-1403



female pharmacist

Dr. Susan Ann Brownsberger, PHARMD


Pharmacist
333 Jonquil Cir, Fort Walton Beach, FL 32548
850-461-7686    

female pharmacist

Dr. Suzanne Marie Thompson, PHARM. D.


Pharmacist
825 Beal Pkwy Nw, Fort Walton Beach, FL 32547
850-314-0851     850-314-7830

female pharmacist

Dr. Tracy Lynn Mcmorrow, PHARM. D.


Pharmacist
533 Eglin Pkwy Ne, Fort Walton Beach, FL 32547
850-226-8162     850-226-8485

male pharmacist

Tyler Thompson


Pharmacist - Clinician (PhC)/ Clinical Pharmacy Specialist
1000 Mar Walt Dr, Fort Walton Beach, FL 32547
850-863-7572    

female pharmacist

Valerie Petrovsky, PHARMD


Pharmacist
1081 Beal Pkwy Nw, Fort Walton Beach, FL 32547
850-863-4400    

male pharmacist

Mr. Venkata R Magisetty


Pharmacist
Winn-dixie Store #0566, 99 Elgin Parkway Nw, Fort Walton Beach, FL 32548
850-244-1226    

male pharmacist

Walter Rogers, R.PH.


Pharmacist
251 Miracle Strip Pkwy Se, Fort Walton Beach, FL 32548
850-796-1937    

male pharmacist

William Andrew Claybaugh, PHARM.D.


Pharmacist
251 Miracle Strip Pkwy Se, Fort Walton Beach, FL 32548
850-796-1937     850-796-1950


Type of Pharmacists:
Psychiatric Pharmacist: A licensed pharmacist who has demonstrated specialized knowledge and skill in optimizing care of patients with psychiatric illness by assessing and monitoring patients, recognizing drug-induced problems, and recommending appropriate treatment plans.
Oncology Pharmacist: A licensed pharmacist who has demonstrated specialized knowledge and skill in developing, recommending, implementing, monitoring, and modifying pharmacotherapeutic plans to optimize outcomes in patients with malignant diseases.